300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Recruiting
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Ireland
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Radar Ventures

VC Fund

Radar Ventures is a VC fund focused on Biotechnology and Robotics. Radar Ventures operates as an venture capital firm.

Total investments:
22
Last investment:
Lead investor:
5%

Last updated:

Industries Radar Ventures invests in

BiotechnologyRoboticsHealth CareFood and BeverageArtificial Intelligence

Stages Radar Ventures invests in

SeedSeries AVenture - Series UnknownPre-SeedInitial Coin Offering

Countries Radar Ventures invests in

AustraliaUnited StatesNew ZealandHong KongSingapore

Round sizes

Seed $1.8M–$11MSeries A $3.2M–$15MVenture - Series Unknown $19M–$30M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$1.8M–$11M
Series A
$3.2M–$15M
Venture - Series Unknown
$19M–$30M

Investment Focus

Industry

  • Biotechnology 4 (18%)
  • Robotics 3 (14%)
  • Health Care 3 (14%)
  • Food and Beverage 3 (14%)
  • Artificial Intelligence 3 (14%)
See all 35 industries →

Stage

  • Seed 13 (59%)
  • Series A 3 (14%)
  • Venture - Series Unknown 2 (9%)
  • Pre-Seed 1 (5%)
  • Initial Coin Offering 1 (5%)

Country

  • Australia 7 (32%)
  • United States 4 (18%)
  • New Zealand 3 (14%)
  • Hong Kong 1 (5%)
  • Singapore 1 (5%)
See all 6 countries →

Team

NameTitleInvestmentsLinksEmail
Rodney Drury
Rodney Drury General Partner
General Partner Total investments: 4
Find email

Investments

CompanyDescriptionRoundLinks
Acumino offers next-generation, AI powered robot models for the execution of highly dexterous tasks in industrial automation settings. The Acumino AI is trained on the most accurate data of robot interactions and facilitates the deployment of next-generation intelligent robot workers in a fast, scalable, reliable, cost-efficient manner, unlockingunmatched dexterity & ROI. $11.7M / Seed / Jun 24, 2026
OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure. $19.2M / Venture - Series Unknown / Feb 12, 2026
Diag-Nose Medical is a novel diagnostic tool that develops non-Invasive diagnostics for better rhinology treatments. The company is working on an affordable, rapid, and non-invasive self-test to determine the right treatment pathway for patients with acute sinusitis and to promote antibiotic stewardship for clinicians.Diag-Nose Medical flagshipproduct, the “RHINOSENSE” is a point-of-care test that combines non-invasive nasal sampling, lateral flow immunoassays, and host-immune markers to differentiate between viral, bacterial, and allergy mediated sinusitis. $2M / Seed / Jan 30, 2025
Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time. $2.1M / Seed / Dec 19, 2024
Xylo Bio is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications. $8M / Seed / Jun 02, 2024
Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time. $1.9M / Seed / Jan 22, 2024
Eden Brew is a food and beverage company providing a range of animal-free and precision-fermented milk and dairy products. $15.4M / Series A / Oct 03, 2023
Cortical Labs is a biological computing startup that is revolutionizing computing by integrating living neurons into chips. The biOS from Cortical Labs creates their reality and transmits data about it via electrical signals. The activity of the neuron is then translated into actions within that reality. The mind perceives these actions as having apositive or negative impact on biOS, which it then adapts to in order to enhance that feedback. The self-programming, infinitely flexible human neuron is the product of four billion years of evolution. $10M / Seed / Apr 19, 2023
Cortical Labs is a biological computing startup that is revolutionizing computing by integrating living neurons into chips. The biOS from Cortical Labs creates their reality and transmits data about it via electrical signals. The activity of the neuron is then translated into actions within that reality. The mind perceives these actions as having apositive or negative impact on biOS, which it then adapts to in order to enhance that feedback. The self-programming, infinitely flexible human neuron is the product of four billion years of evolution. $10M / Seed / Apr 19, 2023
We’re on a mission to speed up health breakthroughs for everyone.Health breakthrough information lives all over the place and solutions are not being captured from the crowd quickly enough. We are building a home for all voices and insights - for every single health condition.Our mobile app generates daily health breakthroughs with generativeAI and the crowd. We are live on the app store being used by patients/carers with Cerebral Palsy, Long Covid, ME/CFS, and Parkinson's. With MS and Spinal Cord Injury up next.Built by patients and carers to solve a problem we live with every day. Backed by world-class operators and investors, including the founders of Canva, Google Maps, Xero, and Afterwork. Pre-Seed / Jan 01, 2023
See all 22 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Recruiting
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Ireland
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Radar Ventures invest in?

Radar Ventures invests primarily in Biotechnology, Robotics and Health Care startups, most often at Seed and Series A stage. Most of the 22 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Radar Ventures's check size?

Radar Ventures typically joins rounds of $1.8M–$11M at Seed, $3.2M–$15M at Series A and $19M–$30M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Radar Ventures participates in.

How do I contact Radar Ventures?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Radar Ventures?

The team at Radar Ventures includes Rodney Drury (General Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Radar Ventures Find emails